Galectin-9 in Combination with EX-527 Prolongs the Survival of Cardiac Allografts in Mice after Cardiac Transplantation

Transplantation Proceedings

Volumn 47, Issue 6, 2015, Pages 2003-2009

  Tao, Y F ^a   Lin, F ^b   Yan, X Y ^c   Gao, X G ^d   Teng, F ^d   Fu, Z R ^d   Wang, Z X ^a  

^a FUDAN UNIVERSITY   (China)

^b TAIZHOU FIRST PEOPLE S HOSPITAL   (China)

^c PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^d SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ECALECTIN; INTERLEUKIN 17; SELISISTAT; 6-CHLORO-2,3,4,9-TETRAHYDRO-1H-CARBAZOLE-1-CARBOXAMIDE; CARBAZOLE DERIVATIVE; GALECTIN; GALECTIN 9, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CD4+ T LYMPHOCYTE; CELL CULTURE; CELL DIFFERENTIATION; CELL ISOLATION; FLOW CYTOMETRY; GRAFT SURVIVAL; HEART TRANSPLANTATION; HUMAN; IN VITRO STUDY; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL TIME; ALLOGRAFT; ALLOTRANSPLANTATION; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; DISEASE MODEL; GRAFT REJECTION; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; PROCEDURES;

ALLOGRAFTS; ANIMALS; CARBAZOLES; DISEASE MODELS, ANIMAL; GALECTINS; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNE TOLERANCE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; TRANSPLANTATION, HOMOLOGOUS;

EID: 84939439432     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2015.04.091     Document Type: Article

References (39)

1. W.W. Angell, and N.E. Shumway Cardiac valvular replacement: role of the aortic homograft Annu Rev Med 19 1968 207 216
2. P.S. Russell, and H.J. Winn Transplantation N Engl J Med 282 1970 896 906
3. S. Strober, S. Slavin, M. Gottlieb, I. Zan-Bar, D.P. King, R.T. Hoppe, and et al. Allograft tolerance after total lymphoid irradiation (TLI) Immunol Rev 46 1979 87 112
4. P.S. Russell, and A.B. Cosimi Transplantation N Engl J Med 301 1979 470 479
5. P. Cravedi, and P.S. Heeger Immunologic monitoring in transplantation revisited Curr Opin Organ Transplant 17 2012 26
6. M. Savasta, and S. Lentini Incidence of neoplastic disease in cardiac allograft recipients Rev Cardiovasc Med 12 2011 219 226
7. M. Savasta, and S. Lentini Immunology insights into cardiac allograft rejection Rev Cardiovasc Med 12 2011 e68 e76
8. M.S. Lee, W. Finch, G. Weisz, and A.J. Kirtane Cardiac allograft vasculopathy Rev Cardiovasc Med 12 2011 143 152
9. H. Khedmat, and S. Taheri Heart allograft involvement by posttransplant lymphoproliferative disorders: report from the PTLD international survey Exp Clin Transplant 9 2011 258 264
10. T.M. Millington, and J.C. Madsen Innate immunity and cardiac allograft rejection Kidney Int Suppl 78 2010 S18 S21
11. N. Safinia, B. Afzali, K. Atalar, G. Lombardi, and R.I. Lechler T-Cell alloimmunity and chronic allograft dysfunction Kidney Int Suppl 78 2010 S2 S12
12. J. Wieckiewicz, R. Goto, and K.J. Wood T regulatory cells and the control of alloimmunity: from characterisation to clinical application Curr Opin Immunol 22 2010 662 668
13. T.M. Millington, and J.C. Madsen Innate immunity in heart transplantation Curr Opin Organ Transplant 14 2009 571 576
14. H17: contributors to allograft rejection and a barrier to the induction of transplantation tolerance? Transplantation 91 2011 939 945
15. H17 cells on transplant rejection and the induction of tolerance Curr Opin Organ Transplant 15 2010 456 461
16. J. Wada, and Y.S. Kanwar Identification and characterization of galectin-9, a novel beta-galactoside-binding mammalian lectin J Biol Chem 272 1997 6078 6086
17. R. Matsumoto, H. Matsumoto, M. Seki, M. Hata, Y. Asano, S. Kanegasaki, and et al. Human ecalectin, a variant of human galectin-9, is a novel eosinophil chemoattractant produced by T lymphocytes J Biol Chem 273 1998 16976 16984
18. M.S. Lipkowitz, E. Leal-Pinto, J.Z. Rappoport, V. Najfeld, and R.G. Abramson Functional reconstitution, membrane targeting, genomic structure, and chromosomal localization of a human urate transporter J Clin Invest 107 2001 1103 1115
19. M.J. Abedin, M. Hirashima, H. Asakura, Y. Kashio, K. Nakamura, M. Seki, and et al. Selective eosinophil adhesion to fibroblast via IFN-gamma-induced galectin-9 J Immunol 169 2002 5912 5918
20. M. Seki, K.M. Sakata, S. Oomizu, T. Arikawa, A. Sakata, M. Ueno, and et al. Beneficial effect of galectin 9 on rheumatoid arthritis by induction of apoptosis of synovial fibroblasts Arthritis Rheum 56 2007 3968 3976
21. Z. Wiener, B. Kohalmi, P. Pocza, J. Jeager, G. Tolgyesi, S. Toth, and et al. TIM-3 is expressed in melanoma cells and is upregulated in TGF-beta stimulated mast cells J Invest Dermatol 127 2007 906 914
22. F. Cedeno-Laurent, and C.J. Dimitroff Evidence of a novel galectin-9-binding membrane glycoprotein ligand on T helper cells Clin Immunol 1 2012 6 7
23. H17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis Clin Immunol 127 2008 78 88
24. H17 and Treg cells during acute hepatitis C PLoS Pathog 9 2013 344 351
25. H17 cell development in an IL-2-dependent but Tim-3-independent manner Clin Immunol 143 2012 51 58
26. H. Saitoh, Y. Ashino, H. Chagan-Yasutan, T. Niki, M. Hirashima, and T. Hattori Rapid decrease of plasma galectin-9 levels in patients with acute HIV infection after therapy Tohoku J Exp Med 28 2012 157 161
27. H17 and Foxp3+ Treg development by galectin-9 secretion PLoS One 7 2012 3725 3744
28. F. Wang, J. Xu, Y. Liao, Y. Wang, C. Liu, X. Zhu, and et al. Tim-3 ligand galectin-9 reduces IL-17 level and accelerates Klebsiella pneumoniae infection Cell Immunol 269 2011 22 28
29. U.H. Beier, L.Q. Wang, T.R. Bhatti, Y.J. Liu, R.X. Han, G.H. Ge, and et al. Sirtuin-1 targeting promotes Foxp3 T-regulatory cell function and prolongs allograft survival Mol Cell Biol 31 2011 1022 1029
30. H17-mediated skin inflammation Clin Immunol 132 2009 184 194
31. + TCR transgenic mouse Am J Transplant 3 2003 381 389
32. H17 cells and transplant acceptance Transplantation 90 2010 945 948
33. H17 promotes acute rejection following liver transplantation in rats J Zhejiang Univ Sci B 11 2010 819 827
34. H17 differentiation in rat liver allografts Transplant Proc 42 2010 3784 3792
35. 2+ entry through ORAI1 is critical for T cell-mediated autoimmunity and allograft rejection J Immunol 185 2010 5845 5858
36. H17 lymphocytes during acute cellular rejection in liver transplant recipients Hepatobiliary Pancreat Dis Int 11 2012 606 611
37. E. Fábrega, M. López-Hoyos, D.S. Segundo, F. Casafont, and F. Pons-Romero Changes in the serum levels of interleukin-17/interleukin-23 during acute rejection in liver transplantation Liver Transpl 15 2009 629 633
38. H2-cell-mediated eosinophilic airway inflammation in mice Am J Resp Crit Care 178 2008 1023 1032
39. H17 pathway in atopic dermatitis compared to psoriasis J Immunol 181 2008 7420 7427